Symbols / BGLC $2.21 -2.72% BioNexus Gene Lab Corp.

Basic Materials • Specialty Chemicals • Malaysia • NCM
BGLC Chart
About

BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It also develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Fundamentals
Scroll to Statements
Sector Basic Materials Industry Specialty Chemicals Market Cap 5.22M
Enterprise Value 1.31M Income -2.30M Sales 9.47M
Book/sh 3.79 Cash/sh 1.61 Dividend Yield —
Payout 0.00% Employees 30 IPO —
P/E — Forward P/E — PEG —
P/S 0.55 P/B 0.58 P/C —
EV/EBITDA -0.56 EV/Sales 0.14 Quick Ratio 6.81
Current Ratio 8.30 Debt/Eq 3.43 LT Debt/Eq —
EPS (ttm) -1.28 EPS next Y — EPS Growth —
Revenue Growth -3.30% Earnings — ROA -16.43%
ROE -28.35% ROIC — Gross Margin 14.77%
Oper. Margin -30.26% Profit Margin -24.27% Shs Outstand 2.36M
Shs Float 1.29M Short Float 1.15% Short Ratio 2.51
Short Interest — 52W High 15.60 52W Low 1.92
Beta 2.31 Avg Volume 21.00K Volume 1.58K
Target Price — Recom None Prev Close $2.27
Price $2.21 Change -2.72%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$2.21
Latest analyst target
3. DCF / Fair value
$-15.40
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.21
Low
—
High
—
Mean
—
News
RSS: Latest BGLC news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
9.51
-2.66%
9.77
-10.60%
10.93
-18.21%
13.36
Operating Revenue
9.51
-2.66%
9.77
-10.60%
10.93
-18.21%
13.36
Cost Of Revenue
8.22
-2.61%
8.44
-12.70%
9.67
-12.85%
11.10
Reconciled Cost Of Revenue
8.22
-2.61%
8.44
-12.70%
9.67
-12.85%
11.10
Gross Profit
1.29
-3.01%
1.33
+5.60%
1.26
-44.46%
2.27
Operating Expense
3.25
-26.37%
4.41
+184.42%
1.55
+28.00%
1.21
Research And Development
0.05
-13.59%
0.05
—
—
Selling General And Administration
4.00
+31.74%
3.04
+75.76%
1.73
+35.37%
1.28
Selling And Marketing Expense
2.03
+240.23%
0.60
—
—
General And Administrative Expense
1.97
-19.19%
2.44
+41.25%
1.73
+35.37%
1.28
Other Gand A
1.97
-19.19%
2.44
+41.25%
1.73
+35.37%
1.28
Other Operating Expenses
—
-0.49
-171.10%
-0.18
-169.63%
-0.07
Total Expenses
11.47
-10.76%
12.85
+14.53%
11.22
-8.83%
12.31
Operating Income
-1.96
+36.46%
-3.08
-957.65%
-0.29
-127.58%
1.06
Total Operating Income As Reported
-1.57
+39.32%
-2.59
-790.73%
-0.29
-127.58%
1.06
EBITDA
-1.42
+42.84%
-2.49
-1237.85%
-0.19
-115.96%
1.16
Normalized EBITDA
-1.60
+44.18%
-2.86
-1439.87%
-0.19
-115.96%
1.16
Reconciled Depreciation
0.15
+41.25%
0.11
+2.85%
0.11
-2.58%
0.11
EBIT
-1.57
+39.32%
-2.59
-790.73%
-0.29
-127.58%
1.06
Total Unusual Items
0.18
-53.10%
0.38
—
—
Total Unusual Items Excluding Goodwill
0.18
-53.10%
0.38
—
—
Net Income
-1.60
+39.20%
-2.63
-638.57%
-0.36
-147.36%
0.75
Pretax Income
-1.59
+38.84%
-2.61
-758.71%
-0.30
-129.12%
1.04
Net Non Operating Interest Income Expense
0.13
+131.06%
0.05
+538.71%
-0.01
+3.81%
-0.01
Interest Expense Non Operating
0.02
+51.81%
0.01
+11.62%
0.01
-3.81%
0.01
Net Interest Income
0.13
+131.06%
0.05
+538.71%
-0.01
+3.81%
-0.01
Interest Expense
0.02
+51.81%
0.01
+11.62%
0.01
-3.81%
0.01
Interest Income Non Operating
0.15
+114.99%
0.07
—
—
Interest Income
0.15
+114.99%
0.07
—
—
Other Income Expense
0.24
-43.59%
0.42
—
—
Other Non Operating Income Expenses
0.06
+41.13%
0.04
—
—
Gain On Sale Of Security
0.18
-53.10%
0.38
—
—
Tax Provision
0.00
-83.77%
0.02
-58.85%
0.05
-82.04%
0.29
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
-14.07%
0.00
Tax Effect Of Unusual Items
0.04
-53.10%
0.09
0.00
0.00
Net Income Including Noncontrolling Interests
-1.60
+39.20%
-2.63
-638.57%
-0.36
-147.36%
0.75
Net Income From Continuing Operation Net Minority Interest
-1.60
+39.20%
-2.63
-638.57%
-0.36
-147.36%
0.75
Net Income From Continuing And Discontinued Operation
-1.60
+39.20%
-2.63
-638.57%
-0.36
-147.36%
0.75
Net Income Continuous Operations
-1.60
+39.20%
-2.63
-638.57%
-0.36
-147.36%
0.75
Normalized Income
-1.73
+40.56%
-2.91
-718.69%
-0.36
-147.36%
0.75
Net Income Common Stockholders
-1.60
+39.20%
-2.63
-638.57%
-0.36
-147.36%
0.75
Diluted EPS
-0.90
+45.78%
-1.66
-260.87%
-0.46
-195.83%
0.48
Basic EPS
-0.90
+45.78%
-1.66
-260.87%
-0.46
-195.83%
0.48
Basic Average Shares
1.78
+12.24%
1.59
+10.17%
1.44
+0.99%
1.43
Diluted Average Shares
1.78
+12.24%
1.59
+10.17%
1.44
+0.99%
1.43
Diluted NI Availto Com Stockholders
-1.60
+39.20%
-2.63
-638.57%
-0.36
-147.36%
0.75
Provision For Doubtful Accounts
-0.81
-161.31%
1.31
—
—
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
10.43
-8.47%
11.40
+30.43%
8.74
-8.71%
9.57
Current Assets
7.43
-7.66%
8.05
+33.63%
6.02
-15.78%
7.15
Cash Cash Equivalents And Short Term Investments
4.38
-26.17%
5.93
+179.84%
2.12
-0.24%
2.12
Cash And Cash Equivalents
4.38
-26.17%
5.93
+179.84%
2.12
-0.24%
2.12
Cash Equivalents
2.79
-15.47%
3.31
+119.33%
1.51
-2.48%
1.55
Cash Financial
1.58
-39.65%
2.62
+328.86%
0.61
+5.76%
0.58
Receivables
1.66
+69.89%
0.98
-66.51%
2.93
-14.88%
3.44
Accounts Receivable
1.38
+72.14%
0.80
-72.12%
2.87
-14.55%
3.36
Gross Accounts Receivable
1.89
-10.10%
2.11
-26.54%
2.87
-14.65%
3.36
Allowance For Doubtful Accounts Receivable
-0.52
+60.39%
-1.31
-10277.05%
-0.01
-230.80%
-0.00
Other Receivables
0.20
+66.35%
0.12
+385.07%
0.03
-68.26%
0.08
Taxes Receivable
0.08
+46.15%
0.06
+82.52%
0.03
0.00
Inventory
1.39
+22.05%
1.14
+16.36%
0.98
-35.75%
1.52
Finished Goods
1.39
+22.05%
1.14
+16.36%
0.98
-35.75%
1.52
Current Deferred Assets
—
—
0.00
-100.00%
0.07
Total Non Current Assets
3.00
-10.43%
3.35
+23.35%
2.72
+12.12%
2.42
Net PPE
1.74
+5.15%
1.65
+5.47%
1.57
-6.45%
1.68
Gross PPE
2.54
+9.65%
2.31
+5.86%
2.18
-0.76%
2.20
Accumulated Depreciation
-0.80
-20.94%
-0.66
-6.84%
-0.62
-17.37%
-0.53
Properties
1.51
+0.00%
1.51
+0.00%
1.51
+0.00%
1.51
Machinery Furniture Equipment
0.49
+65.11%
0.30
+12.54%
0.27
+0.52%
0.26
Construction In Progress
0.00
-100.00%
0.11
0.00
—
Other Properties
0.53
+34.75%
0.40
-3.62%
0.41
-4.23%
0.43
Investments And Advances
1.27
-25.57%
1.70
+47.70%
1.15
+53.65%
0.75
Other Investments
1.27
-25.57%
1.70
+47.70%
1.15
+53.65%
0.75
Total Liabilities Net Minority Interest
2.11
+21.19%
1.74
-16.06%
2.08
-13.34%
2.39
Current Liabilities
1.95
+19.64%
1.63
-18.62%
2.00
-13.94%
2.33
Payables And Accrued Expenses
1.80
+13.05%
1.60
-18.74%
1.96
-9.96%
2.18
Payables
1.80
+13.05%
1.60
-18.74%
1.96
-9.96%
2.18
Accounts Payable
1.50
+7.21%
1.40
-24.66%
1.86
-7.52%
2.01
Other Payable
0.28
+57.04%
0.18
+75.01%
0.10
+43.94%
0.07
Total Tax Payable
—
—
0.00
-100.00%
0.10
Current Debt And Capital Lease Obligation
0.05
+46.73%
0.03
+109.02%
0.02
-58.06%
0.04
Current Capital Lease Obligation
0.05
+46.73%
0.03
+109.02%
0.02
-58.06%
0.04
Current Deferred Liabilities
0.10
0.00
-100.00%
0.02
-78.51%
0.11
Current Deferred Revenue
0.10
0.00
-100.00%
0.02
-78.51%
0.11
Total Non Current Liabilities Net Minority Interest
0.16
+43.89%
0.11
+56.20%
0.07
+7.92%
0.07
Long Term Debt And Capital Lease Obligation
0.16
+61.74%
0.10
+145.64%
0.04
+7.39%
0.04
Long Term Capital Lease Obligation
0.16
+61.74%
0.10
+145.64%
0.04
+7.39%
0.04
Non Current Deferred Liabilities
0.00
-100.00%
0.01
-60.30%
0.03
+8.62%
0.03
Non Current Deferred Taxes Liabilities
0.00
-100.00%
0.01
-60.30%
0.03
+8.62%
0.03
Stockholders Equity
8.32
-13.82%
9.66
+44.90%
6.67
-7.17%
7.18
Common Stock Equity
8.32
-13.82%
9.66
+44.90%
6.67
-7.17%
7.18
Capital Stock
17.33
+0.82%
17.19
+57.29%
10.93
+1.39%
10.78
Common Stock
17.33
+0.82%
17.19
+57.29%
10.93
+1.39%
10.78
Share Issued
1.80
+1.70%
1.77
+22.04%
1.45
+1.46%
1.43
Ordinary Shares Number
1.80
+1.70%
1.77
+22.04%
1.45
+1.46%
1.43
Additional Paid In Capital
-5.01
+0.00%
-5.01
+0.00%
-5.01
+0.00%
-5.01
Retained Earnings
-3.44
-86.66%
-1.84
-259.49%
1.16
-23.54%
1.51
Gains Losses Not Affecting Retained Earnings
-0.56
+18.06%
-0.68
-65.57%
-0.41
-307.99%
-0.10
Other Equity Adjustments
-0.56
+18.06%
-0.68
-65.57%
-0.41
-307.99%
-0.10
Total Equity Gross Minority Interest
8.32
-13.82%
9.66
+44.90%
6.67
-7.17%
7.18
Total Capitalization
8.32
-13.82%
9.66
+44.90%
6.67
-7.17%
7.18
Working Capital
5.48
-14.60%
6.42
+59.69%
4.02
-16.66%
4.82
Invested Capital
8.32
-13.82%
9.66
+44.90%
6.67
-7.17%
7.18
Total Debt
0.21
+57.84%
0.13
+134.95%
0.06
-26.22%
0.08
Capital Lease Obligations
0.21
+57.84%
0.13
+134.95%
0.06
-26.22%
0.08
Net Tangible Assets
8.32
-13.82%
9.66
+44.90%
6.67
-7.17%
7.18
Tangible Book Value
8.32
-13.82%
9.66
+44.90%
6.67
-7.17%
7.18
Dueto Related Parties Current
0.02
+30.12%
0.01
0.00
—
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-2.23
-22.61%
-1.82
-430.22%
0.55
+5923.60%
0.01
Cash Flow From Continuing Operating Activities
-2.23
-22.61%
-1.82
-430.22%
0.55
+5923.60%
0.01
Net Income From Continuing Operations
-1.60
+39.20%
-2.63
-638.57%
-0.36
-147.36%
0.75
Depreciation Amortization Depletion
0.15
+41.25%
0.11
+2.85%
0.11
-2.58%
0.11
Depreciation
0.15
+41.25%
0.11
+2.85%
0.11
-2.58%
0.11
Depreciation And Amortization
0.15
+41.25%
0.11
+2.85%
0.11
-2.58%
0.11
Other Non Cash Items
0.03
+248.29%
0.01
+13.90%
0.01
—
Stock Based Compensation
—
0.51
0.00
—
Provisionand Write Offof Assets
-0.81
-185.48%
0.94
0.00
—
Asset Impairment Charge
0.05
+260.68%
0.01
+117.08%
0.01
+55.97%
0.00
Operating Gains Losses
-0.11
-55.18%
-0.07
+40.50%
-0.12
-423.59%
-0.02
Gain Loss On Investment Securities
-0.11
-55.18%
-0.07
+40.50%
-0.12
-423.59%
-0.02
Unrealized Gain Loss On Investment Securities
-0.07
+77.34%
-0.31
-534.13%
0.07
+136.61%
0.03
Gain Loss On Sale Of PPE
—
—
—
0.00
Change In Working Capital
0.12
-2.19%
0.12
-85.84%
0.83
+196.65%
-0.86
Change In Receivables
0.15
-77.30%
0.65
+20.82%
0.54
-7.00%
0.58
Changes In Account Receivables
—
0.65
+20.82%
0.54
-7.00%
0.58
Change In Inventory
-0.25
-56.41%
-0.16
-129.48%
0.54
+257.37%
-0.35
Change In Payables And Accrued Expense
0.20
+153.59%
-0.38
-218.55%
-0.12
+89.86%
-1.18
Change In Payable
0.20
+153.59%
-0.38
-218.55%
-0.12
+89.86%
-1.18
Change In Other Working Capital
0.06
+184.17%
-0.07
-2168.11%
-0.00
-102.85%
0.10
Change In Other Current Liabilities
-0.04
-155.98%
0.08
+160.48%
-0.13
-528.12%
-0.02
Investing Cash Flow
0.42
+123.31%
-1.79
-298.27%
-0.45
+8.17%
-0.49
Cash Flow From Continuing Investing Activities
0.42
+123.31%
-1.79
-298.27%
-0.45
+8.17%
-0.49
Net PPE Purchase And Sale
-0.23
-51.94%
-0.15
-175.79%
-0.05
-1613.19%
-0.00
Purchase Of PPE
-0.23
-51.94%
-0.15
-175.79%
-0.05
-1613.19%
-0.00
Sale Of PPE
—
—
—
0.00
Capital Expenditure
-0.23
-51.94%
-0.15
-175.79%
-0.05
-1613.19%
-0.00
Net Investment Purchase And Sale
0.50
+129.14%
-1.71
-233.44%
-0.51
-0.44%
-0.51
Purchase Of Investment
-0.57
+67.01%
-1.73
-238.55%
-0.51
+0.80%
-0.52
Sale Of Investment
1.07
+3987.73%
0.03
0.00
-100.00%
0.01
Net Business Purchase And Sale
—
—
—
0.00
Net Other Investing Changes
0.08
—
—
—
Financing Cash Flow
0.14
-97.69%
6.27
+5701.10%
0.11
+483.28%
-0.03
Cash Flow From Continuing Financing Activities
0.14
-97.69%
6.27
+5701.10%
0.11
+483.28%
-0.03
Net Issuance Payments Of Debt
—
0.00
+100.00%
-0.03
-29.41%
-0.03
Repayment Of Debt
—
0.00
+100.00%
-0.03
-29.41%
-0.03
Long Term Debt Payments
—
0.00
+100.00%
-0.03
-29.41%
-0.03
Net Long Term Debt Issuance
—
0.00
+100.00%
-0.03
-29.41%
-0.03
Net Common Stock Issuance
—
—
0.15
0.00
Cash Dividends Paid
—
0.00
0.00
—
Net Other Financing Charges
0.14
-97.69%
6.27
+4083.29%
0.15
+7912.50%
-0.00
Changes In Cash
-1.67
-162.86%
2.66
+1169.03%
0.21
+141.11%
-0.51
Effect Of Exchange Rate Changes
0.04
+115.53%
-0.26
-21.04%
-0.21
-39.19%
-0.15
Beginning Cash Position
4.52
+113.21%
2.12
-0.24%
2.12
-23.81%
2.79
End Cash Position
2.89
-36.10%
4.52
+113.21%
2.12
-0.24%
2.12
Free Cash Flow
-2.46
-24.83%
-1.97
-496.18%
0.50
+8195.57%
0.01
Interest Paid Supplemental Data
0.01
+5.34%
0.01
-28.86%
0.01
-3.81%
0.01
Income Tax Paid Supplemental Data
0.04
-39.71%
0.07
-60.71%
0.17
-24.84%
0.23
Common Stock Issuance
—
—
0.15
0.00
Dividends Received CFI
0.07
+10.94%
0.06
-46.78%
0.12
+423.59%
0.02
Interest Paid CFF
—
-0.01
-13.90%
-0.01
—
Issuance Of Capital Stock
—
—
0.15
0.00
Sale Of Business
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category